Drug Discovery 아웃소싱 시장 규모 : 워크플로우, 치료 영역ㅍ약제 유형, 최종사용자별 - 지역별 전망, 경쟁 전략, 부문 예측(-2033년)
Drug Discovery Outsourcing Market Size- By Workflow, By Therapeutic Area, By Drug Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
세계의 Drug Discovery 아웃소싱 시장 규모는 2033년까지 7.71%의 CAGR로 추이하며, 85억 9,000만 달러 규모로 성장할 것으로 예측됩니다.
약리, 바이오테크놀러지, 제약 등 다양한 분야에서 신약 및 치료제를 발굴하는 방법 중 하나는 신약개발 아웃소싱입니다. 이 접근법은 성공률이 상대적으로 낮고, 많은 시간이 소요되는 절차입니다. 그럼에도 불구하고, 업계에서는 크고 작은 사업자들이 신약을 개발하고, 약물의 유효성을 판단하고 보장하기 위한 임상시험 후 검증을 위해 대형 사업자에게 제공합니다.
COVID-19는 신약개발 산업에 큰 영향을 미쳤습니다. 지난 3년간 제약회사와 생명공학 기업에서 백신 탐색에 대한 수요가 높았기 때문입니다. 강력한 항바이러스제를 개발하기 위해서는 제약 연구에 외부의 도움을 받는 것이 필수적입니다. 생명공학 및 제약 분야의 기업이 CRO에 연구를 위탁하고 있었기 때문에 COVID-19는 시장 성장에 큰 영향을 미쳤습니다. 이러한 업무에는 in vitro 및 in vivo 모델을 이용한 기초 연구와 초기 단계의 임상 개발이 포함됩니다.
세계의 Drug Discovery 아웃소싱 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 시장 역학
- 촉진요인·억제요인·기회·과제의 분석
- 시장에 대한 COVID-19의 영향
제5장 시장 변수와 전망
- SWOT 분석
- PESTEL 분석
- Porter's Five Forces 분석
- 히트맵 분석
제6장 경쟁 구도
- 제조 기반 분포·판매 에어리어·제품 유형
- M&A·제휴·제품 발매·협력
제7장 세계의 Drug Discovery 아웃소싱 시장 : 워크플로우별
- 세계 시장 규모의 점유율·예측
- 표적 밸리데이션·기능 인포매틱스
- 리드 식별·후보 최적화
- 전임상 개발
- 표적 식별·스크리닝
- 기타
제8장 세계의 Drug Discovery 아웃소싱 시장 : 치료 영역별
- 세계 시장 규모의 점유율·예측
- 심장혈관
- 중추신경계
- 위장
- 혈액
- 호흡기
- 감염증
- 종양
- 면역
- 기타
제9장 세계의 Drug Discovery 아웃소싱 시장 : 약제 유형별
제10장 세계의 Drug Discovery 아웃소싱 시장 : 최종사용자별
- 시장 규모·시장 점유율의 추이·예측
- 제약·바이오테크놀러지 기업
- 학술기관
- 기타
제11장 세계의 Drug Discovery 아웃소싱 시장 예측
제12장 세계의 Drug Discovery 아웃소싱 시장 : 지역별
- 시장 규모·시장 점유율의 추이·예측
- 아시아태평양
- 유럽
- 중동 및 아프리카
- 북미
- 라틴아메리카
제13장 기업 개요
- Charles River Laboratories
- Curia Global Inc.
- Dalton Pharma Service
- Dr. Reddy's Laboratories
- Discover X Corporation
- Laboratory Corporation of America
- Merck & Co
- Syngene International Ltd.
- TCG Life Science Pvt. Ltd.
- Thermo Fisher Scientific, Inc.
- 기타
제14장 약어 리스트
제15장 참고 링크
제16장 결론
제17장 조사 범위
KSA
Drug Discovery Outsourcing Market Introduction and Overview
According to SPER market research, Drug Discovery Outsourcing Market Size- By Workflow, By Therapeutic Area, By Drug Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033 state that the Drug Discovery Outsourcing Market is predicted to reach USD 8.59 billion by 2033 with a CAGR of 7.71%.
One way to uncover new medications or therapeutics in a variety of sectors, including pharmacology, biotechnology, and pharmaceuticals, is through drug discovery outsourcing. This approach has a relatively poor success rate in drug development and is a labor-intensive procedure. Nonetheless, both large and tiny producers in the industry create novel medications and provide them to well-known competitors for examination after clinical trials to determine and guarantee the medications' efficacy.
Because several pharmaceutical and biotech businesses have been in high demand for vaccine discovery over the last three years, COVID-19 has had a substantial influence on the drug discovery industry. Using outside help for drug research has become essential to creating potent anti-virus therapies. Because businesses in the biotech and pharmaceutical sectors were progressively outsourcing research efforts to CROs, COVID-19 had a major effect on the market's growth. These operations comprised basic research employing in vitro and in vivo models as well as early-stage clinical development.
Scope of the Report:
Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Workflow, By Therapeutic Area, By Drug Type, By End User.
Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered Charles River Laboratories, Curia Global Inc, Dalton Pharma Service, Discover X Corporation, Dr. Reddy's Laboratories, Laboratory Corporation of America Holdings, Merck & Co, Syngene Intentional Ltd, Thermo Fisher Scientific,Inc, TCG Life Science Pvt Ltd.
Drug Discovery Outsourcing Market Segmentation
By Workflow: Based on the Workflow, Global Drug Discovery Outsourcing Market is segmented as; Target Validation and Functional Informatics, Lead Identification and Candidate Optimization, Preclinical Development, Target Identification and Screening, Others.
By Therapeutic Area: Based on the Therapeutic Area, Global Drug Discovery Outsourcing Market is segmented as; Cardiovascular, Central Nervous System, Gastrointestinal, Hematology, Respiration System, Infectious Disease, Oncology, Immunology, Others
By Drug Type: Based on the Drug Type, Global Drug Discovery Outsourcing Market is segmented as; Small Molecules, Large Molecules.
Table of Contents
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 4.2. COVID-19 Impacts of the Global Drug Discovery Outsourcing Market.
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Drug Discovery Outsourcing Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Drug Discovery Outsourcing Market
7. Global Drug Discovery Outsourcing Market, By Workflow(USD Million) 2020-2033
- 7.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2020-2026
- 7.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2027-2033
- 7.3. Target Validation and Functional Informatics
- 7.4. Lead Identification and Candidate Optimization
- 7.5. Preclinical Development
- 7.6. Target Identification and Screening
- 7.7. Others
8. Global Drug Discovery Outsourcing Market, By Therapeutic Area(USD Million) 2020-2033
- 8.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2020-2026)
- 8.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2027-2033)
- 8.3. Cardiovascular
- 8.4. Central Nervous System
- 8.5. Gastrointestinal
- 8.6. Haematology
- 8.7. Respiratory System
- 8.8. Infectious Disease
- 8.9. Oncology
- 8.10. Immunology
- 8.11. Others
9. Global Drug Discovery Outsourcing Market, By Drug Type (USD Million) 2020-2033
- 9.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2020-2026)
- 9.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2027-2033)
- 9.3. Small Molecules
- 9.4. Large Molecules
10. Global Drug Discovery Outsourcing Market, By End User (USD Million) 2020-2033
- 10.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2020-2026)
- 10.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2027-2033)
- 10.3. Pharmaceutical and Biotechnological Companies
- 10.4. Academia Institutions
- 10.5. Others
11. Global Drug Discovery Outsourcing Market Forecast, 2020-2033 (USD Million)
- 11.1. Global Drug Discovery Outsourcing Market Size and Market Share
12. Global Drug Discovery Outsourcing Market, By Region, 2020-2033 (USD Million)
- 12.1. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2020-2026)
- 12.2. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2027-2033)
- 12.3. Asia-Pacific
- 12.3.1. Australia
- 12.3.2. China
- 12.3.3. India
- 12.3.4. Japan
- 12.3.5. South Korea
- 12.3.6. Rest of Asia-Pacific
- 12.4. Europe
- 12.4.1. France
- 12.4.2. Germany
- 12.4.3. Italy
- 12.4.4. Spain
- 12.4.5. United Kingdom
- 12.4.6. Rest of Europe
- 12.5. Middle East and Africa
- 12.5.1. Kingdom of Saudi Arabia
- 12.5.2. United Arab Emirates
- 12.5.3. Qatar
- 12.5.4. South Africa
- 12.5.5. Egypt
- 12.5.6. Morocco
- 12.5.7. Nigeria
- 12.5.8. Rest of Middle-East and Africa
- 12.6. North America
- 12.6.1. Canada
- 12.6.2. Mexico
- 12.6.3. United States
- 12.7. Latin America
- 12.7.1. Argentina
- 12.7.2. Brazil
- 12.7.3. Rest of Latin America
13. Company Profile
- 13.1. Charles River Laboratories
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
- 13.2. Curia Global Inc.
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
- 13.3. Dalton Pharma Service
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
- 13.4. Dr. Reddy's Laboratories
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. Discover X Corporation
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
- 13.6. Laboratory Corporation of America
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. Merck & Co
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. Syngene International Ltd.
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
- 13.9. TCG Life Science Pvt. Ltd.
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
- 13.10. Thermo Fisher Scientific, Inc.
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
- 13.11. Others
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
